Inventor · disambiguated record
Michael N. Alekshun
Also filed as: ALEKSHUN MICHAEL N
7 granted patents·18 pending applications·65 citations·filing 2002–2015
83Inventor score
Top patents by PatentIndex Score
25 records- 0192US7405235B2Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2003·Granted Jul 29, 2008·41 cites·187 claims
- 0283US7075582B2Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2002·Granted Jul 11, 2006·10 cites·7 claims
- 0378US7202339B2Crystals of MarR polypeptides, regulators of multiple antibiotic resistanceUNIV BOSTON·Filed 2002·Granted Apr 10, 2007·8 cites·10 claims
- 0476US8440646B1Substituted tetracycline compounds for treatment of Bacillus anthracis infectionsALEKSHUN MICHAEL N·Filed 2007·Granted May 14, 2013·1 cites·23 claims
- 0575US7829543B2Substituted polyamines as inhibitors of bacterial efflux pumpsPARATEK PHARM INNC·Filed 2004·Granted Nov 9, 2010·4 cites·20 claims
- 0673US8039221B2Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2009·Granted Oct 18, 2011·0 cites·12 claims
- 0773US2011230523A1Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 0871US2010227850A1Methods for preventing and treating microbial infections by modulating transcription factorsPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 0970US9078811B2Methods of increasing oral bioavailability of tetracyclinesALEKSHUN MICHAEL N·Filed 2007·Granted Jul 14, 2015·1 cites·12 claims
- 1062US2006084678A1Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2005·Application pending·0 cites
- 1161US2010298540A1Crystal Structure of a MarR Family PolypeptideTUFTS COLLEGE·Filed 2009·Application pending·0 cites
- 1261US2012209003A1METHODS FOR IDENTIFYING AND USING MarR FAMILY POLYPEPTIDE BINDING COMPOUNDSALEKSHUN MICHAEL N·Filed 2011·Application pending·0 cites
- 1359US2009131401A1Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2008·Application pending·0 cites
- 1456US2007155957A1Crystals of MarR polypeptides, regulators of multiple antibiotic resistanceUNIV BOSTON·Filed 2007·Application pending·0 cites
- 1556US2005064527A1NIMR compositions and their methods of useFiled 2004·Application pending·0 cites
- 1654US2016030451A1Substituted tetracycline compounds for treatment of bacillus anthracis infectionsALEKSHUN MICHAEL N·Filed 2013·Application pending·0 cites
- 1752US2011218168A1Substituted polyamines as inhibitors of bacterial efflux pumpsPARATEK PHARM INNC·Filed 2010·Application pending·0 cites
- 1850US2013144038A1CRYSTAL STRUCTURE OF A MarR FAMILY POLYPEPTIDEALEKSHUN MICHAEL N·Filed 2012·Application pending·0 cites
- 1949US2004106553A1Methods for preventing and treating microbial infections by modulating transcription factorsFiled 2003·Application pending·0 cites
- 2047US2009131481A1Transcription Factor Modulating Compounds and Methods of Use ThereofPARATEK PHARM INNC·Filed 2008·Application pending·0 cites
- 2144US2009170812A1Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2007·Application pending·0 cites
- 2244US2006160799A1Transcription factor modulating compounds and methods of use thereofALEKSHUN MICHAEL N·Filed 2005·Application pending·0 cites
- 2344US2016030453A1Methods of increasing oral bioavailability of tetracyclinesPARATEK PHARM INNC·Filed 2015·Application pending·0 cites
- 2440US2003229065A1Transcription factor modulating compounds and methods of use thereofFiled 2002·Application pending·0 cites
- 2538US2011059962A1Transcription factor modulating compounds and methods of use thereofALEKSHUN MICHAEL N·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael N. Alekshun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →